QIAGEN N.V. (QGEN) Earnings Signals & AI Vibe Check

Based on earningsVibe SuperAnalyst™ synthesis of the latest 20-F, QIAGEN N.V.'s filing signal turned positive.

QIAGEN N.V. is a global provider of Sample to Insight solutions, enabling customers to extract and analyze molecular information from biological samples. The company offers integrated workflows combining consumables, instruments, automation, and bioinformatics software to deliver actionable insights across life sciences and molecular diagnostics markets. QIAGEN serves over 500,000 customers globally, including academic institutions, pharmaceutical companies, and clinical healthcare providers. Its product portfolio is categorized into consumables and related revenues (90% of 2025 sales) and instruments and related services (10% of 2025 sales). With approximately 5,700 employees across over 35 locations worldwide as of December 31, 2025, QIAGEN operates globally with significant markets in the Americas, EMEA, and Asia Pacific.

Revenue is primarily driven by the sale of consumables and related products, which accounted for approximately 90% of total net sales in 2025. The remaining 10% is generated from instruments and related services.